| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.78 |
| 52 Week High | HK$1.09 |
| 52 Week Low | HK$0.72 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -13.33% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -10.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2502 | HK Chemicals | HK Market | |
|---|---|---|---|
| 7D | 1.3% | 3.7% | 5.2% |
| 1Y | n/a | -13.3% | -9.1% |
Return vs Industry: Insufficient data to determine how 2502 performed against the Hong Kong Chemicals industry.
Return vs Market: Insufficient data to determine how 2502 performed against the Hong Kong Market.
Price Volatility
| 2502 volatility | |
|---|---|
| 2502 Average Weekly Movement | 6.1% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.8% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 2502 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2502's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 413 | Zengguang Wang | www.jyqhhg.com |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. engages in the processing, production, distribution, and sale of hydrogenated benzene-based chemicals and energy products in the People’s Republic of China. Its hydrogenated benzene-based chemicals include pure benzene, toluene, and xylene; and energy products comprising liquefied natural gas (LNG) and coal gas.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Fundamentals Summary
| 2502 fundamental statistics | |
|---|---|
| Market cap | HK$745.40m |
| Earnings (TTM) | HK$59.34m |
| Revenue (TTM) | HK$2.52b |
12.6x
P/E Ratio0.3x
P/S RatioIs 2502 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2502 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.33b |
| Cost of Revenue | CN¥2.18b |
| Gross Profit | CN¥148.80m |
| Other Expenses | CN¥93.87m |
| Earnings | CN¥54.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.057 |
| Gross Margin | 6.39% |
| Net Profit Margin | 2.36% |
| Debt/Equity Ratio | 23.0% |
How did 2502 perform over the long term?
See historical performance and comparison